BioHealth News Archive
Viela Bio begins clinical trials months after $250M spinoff – Maryland Daily Record
One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela…
Read MoreAAVogen Expands Science Advisory Board, Completes Another Milestone – PRESS RELEASE
AAVogen Inc., a biotech company that is developing gene therapeutics for muscle wasting disease, welcomes Lawson Macartney, DVM/PhD as the newest member of its…
Read MoreMCEDC Success Series: MedImmune and Bio Excellence
MedImmune is one of the 300+ BioHealth success stories in Montgomery County. Meet JoAnn Suzich, Ph.D., VP of Research and Microbial Sciences, who shares…
Read MoreLife Science Nation Fundraising Bootcamp 8/27 OR 8/28
Are you seeking funding or about to launch a fundraising campaign? Sign up today to attend Life Science Nation’s Fundraising Bootcamp. Pre-registration is required…
Read MoreWIB-Capital Region Presents: HERstory Gala 2018: Honoring Outstanding Women in Biotech
When:Thursday, December 13, 20187:00 p.m. – 10:00 p.m. EST Where:VisArts Rockville155 Gibbs StreetRockville, MD 20850United States The HERstory Gala is the premier event for…
Read MoreJohns Hopkins researchers use deep learning to combat pancreatic cancer | Healthcare IT News
Only 7 percent of patients live five years after diagnosis of pancreatic cancer, the lowest rate for any cancer, according to the American Cancer…
Read MoreFDA approved the first-ever generic version of EpiPen – STAT
The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday — a move the agency says could help lower costs for…
Read MoreCAP Application Deadline Extended to August 23! – NIH SBIR/STTR
Does your small business need assistance in commercializing its HHS SBIR/STTR-funded technology? Was that technology developed with a Phase II HHS SBIR/STTR award that…
Read MoreProfectus BioSciences, Emergent BioSolutions get $36 million to aid in new vaccine development – Baltimore Business Journal
Maryland biotechnology firms Profectus BioSciences Inc. and Emergent BioSolutions Inc. will receive up to $36 million to develop and manufacture a new vaccine against…
Read MoreBioNetworking: Fermenting Innovation – Sept 27th 3:00 PM
This networking event is for BioTech Professionals in the BioHealth Capital Region. We encourage all professionals, post-docs and scientist to attend - it is…
Read MoreDigital OMICS Innovators Meetup – Meetup
Listen to, network with the hottest startup CXOs in the biohealth capital region at our first in a series of four annual meetups around…
Read MoreA Harvard Scientist Thinks He Has a Gene Test for Heart Attack Risk. He Wants to Give It Away Free
A Harvard scientist thinks he's reached a new milestone: a genetic test that helps identify people who are at high risk of having a…
Read MoreNew MCEDC Website Features to Grow Your Business
PROGRAMS AND INCENTIVES TO SPUR BUSINESS GROWTH We help you navigate available programs, grants and incentives to identify immediate opportunities and plan for long-term…
Read MoreGlycoMimetics Receives Japanese Patent For Uproleselan (GMI-1271) – Business Wire
GlycoMimetics, Inc. (NASDAQ: GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases, announced today that the…
Read MorePopper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit
Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that…
Read More